Inorganic cements have found utility in tissue replacement since the late nineteenth century, one of the first examples being calcium sulphates in the augmentation of bone defects. In the intervening period of time countless formulations of calcium phosphate, sulphate and silicate cement have been researched and as a result, many are now commercially available for a variety of biomedical applications. This review summarises the applications, formulations, advantages and drawbacks of such inorganic cements, suggesting future work that will drive progress in this area into the future of biomaterials research.
WilsonAD and NicholsonJW: ‘Acid-base cements; their biomedical and industrial applications’, 1993, Cambridge, Cambridge University Press.
2.
SpicerPP, KretlowJD, YoungS, JansenJA, KasperFK and MikosAG: ‘Evaluation of bone regeneration using the rat critical size calvarial defect’, Nat. Protoc., 2012, 7, (10), 1918–1929.
3.
BrownWE and ChowLC: ‘A new calcium phosphate, water setting cement’, in ‘Cements research progress’ (ed. P. W. Brown), 352–379; 1986, Westerville, OH, The American Ceramic Society.
4.
MonmaH and KanazawaT: ‘The hydration of α-tricalcium phosphate’, Yogo-kyokai-shi, 1976, 84, 209–213.
5.
KingeryWD: ‘Cold-setting properties’, J. Am. Ceram. Soc., 1950, 8, 242–247.
6.
HofmannMP: ‘Physikalische Charakterisierung von Calciumphosphat-Pulvern zur Einstellung von Prozessparametern für die Herstellung von Knochenzement’, PhD thesis, University of Wuerzburg, Wuerzburg, Germany, 2003.
7.
IshikawaK, TakagiS, ChowLC and SuzukiK: ‘Reaction of calcium phosphates with different amounts of tetracalcium phosphate and dicalcium phosphate anhydrous’, J. Biomed. Mater. Res., 1999, 46, 504–510.
8.
KumarR and BhattacharjeeB: ‘Porosity, pore size distribution and in situ strength of concrete’, Cem. Concr. Res., 2003, 33, 155–164.
9.
GbureckU, BarraletJE, SpatzK, GroverLM and ThullR: ‘Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement’, Biomaterials, 2004, 25, (11), 2187–2195.
10.
ConstantzBR, BarrBM, IsonIC, FulmerMT, BakerJ, McKinneyL, GoodmanSB, GunasekarenS, DelaneyDC, RossJ and PoserRD: ‘Histological, chemical and crystallographic analysis of four calcium phosphate cements in different rabbit osseus sites’, J. Biomed. Mater. Res. A, 1998, 43A, 451–461.
11.
TofighiA, MounicS, ChakravarthyP, ReyC and LeeD: ‘Setting reactions involved in injectable cements based on amorphous calcium phosphate’, Key Eng. Mater., 2000, 192, (1), 769–772.
12.
GbureckU, GrolmsO, BarraletJE, GroverLM and ThullR: ‘Mechanical activation and cement formation of beta-tricalcium phosphate’, Biomaterials, 2003, 24, (23), 4123–4131.
13.
JamshidiP: unpublished work, 2013.
14.
LemaitreJ, MirtchiAA and MortierA: ‘Calcium phosphate cement for medical use: state of the art and perspectives of development’, Silic. Ind., 1987, 10, 141–146.
15.
BohnerM, LemaitreJ and RingTA: ‘Effects of sulphate, pyrophosphate, and citrate ions on the physiochemical properties of cements made from β-tricalcium phosphate- phosphoric acid-water mixtures’, J. Am. Ceram. Soc., 1996, 79, 1427–1434.
16.
DriessensFCM, BoltongMG, BermudezO and PlanellJA: ‘Formulation and setting times of some calcium orthophosphate cements - a pilot-study’, J. Mater. Sci. – Mater. M, 1993, 4, 503–508.
17.
BohnerM, MerkleHP, Van LanduytP, TrophardyG and LemaitreJ: ‘Effects of several additives and their admixtures on the physicochemical properties of a calcium phosphate cement’, J. Mater. Sci. – Mater. M, 2000, 11, 111–116.
18.
GroverLM, KnowlesJC, FlemingGJ and BarraletJE: ‘In vitro ageing of brushite calcium phosphate cement’, Biomaterials, 2003, 24, (23), 4133–4141.
19.
LilleyKJ, GbureckU, KnowlesJC, FarrarDF and BarraletJE: ‘Cement from magnesium substituted hydroxyapatite’, J. Mater. Sci. Mater. Med., 2005, 16, (5), 455–460.
20.
GroverLM, GbureckU, WrightAJ, TremayneM and BarraletJE: ‘Biologically mediated resorption of brushite cement in vitro’, Biomaterials, 2006, 27, (10), 2178–2185.
21.
GroverLM, WrightAJ, GbureckU, BolarinwaA, SongJ, LiuY, FarrarDF, HowlingG, RoseJ and BarraletJE: ‘The effect of amorphous pyrophosphate on calcium phosphate cement resorption and bone generation’, Biomaterials, 2013, 34, (28), 6631–6637.
22.
HabibovicP, GbureckU, DoillonCJ, BassettDC, van BlitterswijkCA and BarraletJE: ‘Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants’, Biomaterials, 2008, 29, (7), 944–953.
23.
BarraletJE, GbureckU, HabibovicP, VorndranE, GerardC and DoillonCJ: ‘Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release’, Tissue Eng. Part A, 2009, 15A, (7), 1601–1609.
24.
WirschingF: ‘Caclium sulphate’, in ‘Ullmann's encylopedia of industrial chemistry’;2000, Wiley: Weinheim.
25.
LewryAJ and WilliamsonJ: ‘The setting of gypsum plaster’, J. Mater. Sci., 1994, 29, (20), 5279–5284.
26.
de KorteACJ and BrouwersHJH: ‘Hydration modeling of calcium sulphates’, International Conference on ‘Construction and Building Technology’, kuala lumpur, Malaysia, June 2008, IACT.
27.
RidgeMJ and SurkeviciusH: ‘Variations in the kinetics of setting of calcined gypsum. I. Effects of retarders and accelerators’, J. Appl. Chem., 1961, 11, (11), 420–427.
28.
BarraletJE, GauntT, WrightAJ, GibsonIR and KnowlesJC: ‘Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement’, J. Biomed. Mater. Res., 2002, 63, (1), 1–9.
29.
DewiAH, AnaID, WolkeJ and JansenJ: ‘Behavior of plaster of Paris-calcium carbonate composite as bone substitute. A study in rats’, J. Biomed. Mater. Res. A, 2013, 101A, (8), 2143–2150.
30.
YangJ, WuH, TengN, JiD and LeeS: ‘Novel attempts for the synthesis of calcium sulfate hydrates in calcium chloride solutions under atmospheric conditions’, Ceram. Int., 2012, 38, 381–387.
31.
WangP, LeeEJ, ParkCS, YoonBH, ShinDS and KimHE: ‘Calcium sulfate hemihydrate powders with a controlled morphology for use as bone cement’, J. Am. Ceram. Soc., 2008, 91, (6), 2039–2042.
32.
ChenJ, GaoJ, YinH, LiuF, WangA, ZhuY, WuZ, JiangT, QinD, ChenB, JiY and SunM: ‘Size-controlled preparation of α-calcium sulphate hemihydrate starting from calcium sulphate dihydrate in the presence of modifiers and the dissolution rate in simulated body fluid’, Mater. Sci. Eng. C – Mater. Biol. Appl., 2013, 33, (6), 3256–3262.
33.
DressmannH: ‘Ueber Knockenplombierung bei Hohlenforming Defekten des Knochens’, Beitr. Klin. Chir., 1892, 9, 804–810.
34.
PeltierL, BickelE, LilloR and TheinM: ‘The use of plaster of paris to fill defects in bone’, Ann. Surg., 1957, 146, (1), 61–69.
35.
PeltierLF and JonesRF: ‘Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets’, J. Bone Joint Surg. Am., 1978, 60, (6), 820–822.
36.
NilssonM, WangJS, WielanekL, TannerKE and LidgrenL: ‘Biodegradation and biocompatability of a calcium sulphate-hydroxyapatite bone substitute’, J. Bone Joint Surg. Br., 2004, 86, (1), 120–125.
37.
StubbsD, DeakinM, Chapman-SheathP, BruceW, DebesJ, GilliesRM and WalshWR: ‘In vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model’, Biomaterials, 2004, 25, (20), 5037–5044.
38.
TurnerTM, UrbanRM, GitelisS, HaggardWO and RichelsophK: ‘Resorption evaluation of a large bolus of calcium sulfate in a canine medullary defect’, Orthopedics, 2003, 26, (5), 577–579.
39.
OrsiniG, RicciJ, ScaranoA, PecoraG, PetroneG, IezziG and PiattelliA: ‘Bone-defect healing with calcium-sulfate particles and cement: an experimental study in rabbit’, J. Biomed. Mater. Res. Part B, Appl. Biomater., 2004, 68, (2), 199–208.
40.
ScaranoA, OrsiniG, PecoraG, IezziG, PerrottiV and PiattelliA: ‘Peri-implant bone regeneration with calcium sulfate: a light and transmission electron microscopy case report’, Implant Dent., 2007, 16, (2), 195–203.
41.
KimSG, YeoHH and KimYK: ‘Grafting of large defects of the jaws with a particulate dentin-plaster of paris combination’, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1999, 88, (1), 22–25.
42.
LeiD, ZhanzhongM, HuaikuoY, LeiX and GongboY: ‘Treatment of distal radius bone defects with injectable calcium sulphate cement’ in ‘Bone grafting’ (eds. Zorzi and Miranda); 2012, InTech:Rijeka: pp 125–134.
43.
RobinsonD, AlkD, SandbankJ, FarberR and HalperinN: ‘Inflammatory reactions associated with a calcium sulphate substitute’, Ann. Transpl., 1999, 4, (3–4), 91–97.
44.
HingKA, WilsonLF and BucklandT: ‘Comparative performance of three ceramic bone graft substitutes’, Spine J., 2007, 7, (4), 475–490.
45.
OSTEOSET®T Bone Graft Products 130764-4, Wright Medical Technology, Inc., Memphis, TN, USA
46.
WilkinsRM, KellyCM and GiustiDE: ‘Bioassayed demineralized bone matrix and calcium sulfate: use in bone-grafting procedures’, Ann. Chir. Gynaecol., 1999, 88, 180–185.
47.
CoetzeeAS: ‘Regeneration of bone in the presence of calcium sulphate’, Arch Otolaryngol., 1980, 106, 405–409.
48.
KamedaT, ManoH, YamadaY, TakaiH, AmizukaH, KoboriM, IzumiN, KawashimaH, OzawaH, IkedaK, KamedaA, HakedaY and KumegawaM: ‘Calcium-sensing receptor in mature osteoclasts, which are bone-resorbing cells’, Biochem. Biphys. Res. Commun., 1998, 245, 419–422.
49.
WalshWR, MorbergP, YuY, YangJL, HaggardW, SheathPC, SvehlaM and BruceWJ: ‘Response of calcium sulfate bone substitute in a confined cancellous defects’, Clin. Orthop., 2003, 406, 228–236.
50.
SidquiM, CollinP, VitteC and ForestN: ‘Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate’, Biomaterials, 1993, 16, 1327–1332.
51.
PodaropoulosL, VeisAA, PapadimitriouS, AlexandridisC and KalyvasD: ‘Bone regeneration using beta-tricalcium phosphate in a calcium sulfate matrix’, J. Oral Implantol., 2009, 35, (1), 28–36.
52.
CaiZY, YangDA, ZhangN, JiCG, ZhuL and ZhangT: ‘Poly(propylene fumarate)/(calcium sulphate/β-tricalcium phosphate) composites: Preparation, characterization and in vitro degradation’, Acta Biomater., 2009, 5, (2), 628–635.
53.
CaiZ, ZhangT, DiL, XuDM, XuDH and YangDA: ‘Morphological and hifstological analysis on the in vivo degradation of poly (propylene fumarate)/(calcium sulfate/β-tricalcium phosphate)’, Biomed. Microdevices, 2011, 13, (4), 623–631.
54.
IntiniG, AndreanaS, IntiniFE, BuhiteRJ and BobekLA: ‘Calcium sulfate and platelet-rich plasma make a novel osteoinductive biomaterial for bone regeneration’, J. Transl. Med., 2007, 5, (13), available at: https://dx-doi-org.web.bisu.edu.cn/10.1186/1479-5876-5-13
55.
KutkutA, AndreanaS, KimHL and MonacoEJr: ‘Extraction socket preservation graft before implant placement with calcium sulfate hemihydrate and platelet-rich plasma: a clinical and histomorphometric study in humans’, J. Periodontol., 2012, 83, (4), 401–409.
56.
LeonardisD and PecoraG: ‘prospective study on the augmentation of the maxillary sinus with calcium sulfate: histological results’, J. Periodontol., 2000, 71, (6), 940–947.
57.
AlGhamdiAST: ‘Osteotome maxillary sinus lift using bovine bone and calcium sulfate: a case series’, Clin. Implant Dent. Relat. Res., 2013, 15, (2), 153–159.
58.
GuarnieriR, AldiniNN, PecoraG, FiniM and GiardinoR: ‘Medical-grade calcium sulfate hemihydrate (surgiplaster) in healing of a human extraction socket-histologic observation at 3 months: a case report’, Int. J. Oral Maxillofac. Implants, 2005, 20, (4), 636–641.
59.
ChoyWS, KimKJ, LeeSK, SD and ParkHJ: ‘Treatment for hand enchondroma with curettage and calcium sulfate pellet (OsteoSet) grafting’, Eur. J. Orthop. Surg. Traumatol., 2012, 22, 295–299.
60.
BajadaS, HarrisonPE, AshtonBA, Cassar-PullicinoVN, AshammakhiN and RichardsonJB: ‘Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation’, J. Bone Joint Surg. Br., 2007, 89, (10), 1382–1386.
61.
MaedaST, BramaneCM, TagaR, GarciaRB, de MoraesIG and BernadineliN: ‘Evaluation of surgical cavities filled with three types of calcium sulfate’, J. Appl. Oral Sci.: Rev. FOB, 2008, 15, (5), 416–419.
62.
FurlanetoFAC, NagataMJH, FuciniSE, DeliberadorTM, OkamotoT and MessoraMR: ‘Bone healing in critical-size defects treated with bioactive glass/calcium sulfate: a histologic and histometric study in rat calvaria’, Clin. Oral Implants Res., 2007, 18, (3), 311–318.
63.
HadjipavlouAJ, SimmonsJW, TzermiadianosMN, KatonisPG and SimmonsJD: ‘Plaster of Paris as bone substitute in spinal surgery’, Eur. Spine J., 2001, 10, 189–196.
64.
YangHL, ZhuXS, ChenL, ChenCM, ManghamDC, CoultonLA and AikenSS: ‘Bone healing response to a synthetic calcium sulfate/β-tricalcium phosphate graft material in a sheep vertebral body defect model’, J. Biomed. Mater. Res. B: Appl. Biomater., 2012, 100, (7), 1911–1921
65.
VorndranE, GeffersM, EwaldA, LemmM, NiesB and GbureckU: ‘Ready-to-use injectable calcium phosphate bone cement paste as a drug carrier’, Acta Biomater., 2013, 9, (12), 9558–9567.
66.
RosenblumSF, FrenkelS, RicciJR and AlexanderH: ‘Diffusion of fibroblast growth factor from a plaster of Paris carrier’, J. Appl. Biomater., 1993, 4, (1), 67–72.
ParkerAC, SmithJK, CourntneyHS and HaggardWO: ‘Evaluation of two sources of calcium sulphate for a local drug delivery system: a pilot study’, Clin. Orthop. Relat. Res., 2011, 469, (11), 3008–3015.
69.
TorayaH and YamazakiS: ‘Simulated annealing structure solution of a new phase of dicalcium silicate Ca2SiO4 and the mechanism of structural changes from [alpha]-dicalcium silicate hydrate to [alpha]L'-dicalcium silicate via the new phase’, Acta Crystallogr. Sect. B, 2002, 58, 613–621.
70.
HuangXH and ChangJ: ‘Low-temperature synthesis of nanocrystalline β-dicalcium silicate with high specific surface area’, J. Nanopart Res., 2007, 9, 1195–1200.
71.
YanniT, YongL, ZhibingZ, HofmannM and GroverL: ‘Comparing three methods for the synthesis of pure beta-dicalcium silicate’, Proc. 4th Int. Conf. on ‘Bioinformatics and biomedical engineering (iCBBE)’, Chengdu, China, June2010.
72.
RodriguesFA: ‘Synthesis of chemically and structurally modified dicalcium silicate’, Cem. Concr. Res., 2003, 33, 823–827.
73.
XiaW and ChangJ: ‘Preparation and the phase transformation behavior of amorphous mesoporous calcium silicate’, Microporous Mesoporous Mater., 2008, 108, 345–351.
74.
LiX, ShiJ, ZhuY, ShenW, LiH, LiangJ and GaoJ: ‘A template route to the preparation of mesoporous amorphous calcium silicate with high in vitro bone-forming bioactivity’, J. Biomed. Mater. Res. Part B: Appl. Biomater., 2007, 83B, 431–439.
75.
DingSJ, ShieMY and WangCY: ‘Novel fast-setting calcium silicate bone cements with high bioactivity and enhanced osteogenesis in vitro’, J. Mater. Chem., 2009, 19, 1183–1190.
76.
SprioS, TampieriA, CelottiG and LandiE: ‘Development of hydroxyapatite/calcium silicate composites addressed to the design of load-bearing bone scaffolds’, J. Mech. Behav. Biomed. Mater., 2009, 2, 147–155.
77.
RobertsHW, TothJM, BerzinsDW and CharltonDG: ‘Mineral trioxide aggregate material use in endodontic treatment: A review of the literature’, Dent. Mater., 2008, 24, 149–164.
78.
LamyD, PierreAC and HeimannRB: ‘Hydroxyapatite coatings with a bond coat of biomedical implants by plasma projection’, J. Mater. Res., 1996, 11, 680–686.
79.
LiuX, TaoS and DingC: ‘Bioactivity of plasma sprayed dicalcium silicate coatings’, Biomaterials, 2002, 23, 963–968.
80.
GouZ and ChangJ: ‘Synthesis and in vitro bioactivity of dicalcium silicate powders’, J. Eur. Ceram. Soc., 2004, 24, 93–99.
81.
GouZG, ChangJ, ZhaiWY and WangJY: ‘Study on the self-setting property and the in vitro bioactivity of beta-Ca2SiO4’, J. Biomed. Mater. Res. Part B–Appl. Biomater., 2005, 73B, 244–251.
82.
ZhaoW and ChangJ: ‘Sol-gel synthesis and in vitro bioactivity of tricalcium silicate powders’, Mater. Lett., 2004, 58, 2350–2353.
83.
ZhaoW, WangJ, ZhaiW, WangZ and ChangJ: ‘The self-setting properties and in vitro bioactivity of tricalcium silicate’, Biomaterials, 2005, 26, 6113–6121.
84.
TaddeiP, TintiA, GandolfiMG, RossiPL and PratiC: ‘Ageing of calcium silicate cements for endodontic use in simulated body fluids: a micro-Raman study’, J. Raman Spectrosc., 2009, 40, 1858–1866.
85.
WuJ, ZhuYJ, ChenF, ZhaoXF, ZhaoJ and QiC: ‘Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers’, Dalton Trans., 2013, 42, 7032–7040.
86.
WuC, RamaswamyY, SoepartoA and ZreiqatH: ‘Incorporation of titanium into calcium silicate improved their chemical stability and biological properties’, J. Biomed. Mater. Res. Part A, 2008, 86A, 402–410.
87.
ZhuYF, ZhuM, HeX, ZhangJH and TaoCL: ‘Substitutions of strontium in mesoporous calcium silicate and their physicochemical and biological properties’, Acta Biomater., 2013, 9, 6723–6731.
88.
LuJW, WeiJ, GanQ, LuX, HouJ, SongWH, YanY, MaJ, GuoH, XiaoT and LiuC: ‘Preparation, bioactivity, degradability and primary cell responses to an ordered mesoporous magnesium-calcium silicate’, Microporous Mesoporous Mater., 2012, 163, 221–228.
89.
MaMG, LiSM, JiaN, ZhuJF, SunRC and ZhuYJ: ‘Fabrication and characterization of Ag/calcium silicate core-shell nanocomposites’, Mater. Lett., 2011, 65, 3069–3071.
90.
FanY, HuangS, JiangJ, LiG, YangP, LianH, ChengZ and LinJ: ‘Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu3+) as a drug carrier’, J. Colloid Interface Sci., 2011, 357, 280–285.
91.
KangX, HuangS, YangP, MaP, YangD and LinJ: ‘Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route’, Dalton Trans., 2011, 40, 1873–1879.
92.
LinK, ChangJ, ChenG, RuanM and NingC: ‘A simple method to synthesize single-crystalline β-wollastonite nanowires’, J. Cryst. Growth, 2007, 300, 267–271.
93.
WuJ, ZhuYJ, CaoSW and ChenF: ‘Hierachically nanostructured mesoporous spheres of calcium silicate hydrate: surfactant-free sonochemical synthesis and drug-delivery system with ultrahigh drug-loading capacity’, Adv. Mater., 2010, 22, 749–753.
94.
ZhangM and ChangJ: ‘Surfactant-assisted sonochemical synthesis of hollow calcium silicate hydrate (CSH) microspheres for drug delivery’, Ultrason. Sonochem., 2010, 17, 789–792.
95.
HuangY, HanSG, PangXF, DingQQ and YanYJ: ‘Electrodeposition of porous hydroxyapatite/calcium silicate composite coating on titanium for biomedical applications’, Appl. Surf. Sci., 2013, 271, 299–302.
96.
BeheriHH, MohamedKR and El-BassyouniGT: ‘Mechanical and microstructure of reinforced hydroxyapatite/calcium silicate nano-composites materials’, Mater. Des., 2013, 44, 461–468.
97.
ZhaoQ, QianJ, ZhouH, YuanY, MaoY and LiuC: ‘In vitro osteoblast-like and endothelial cells’ response to calcium silicate/calcium phosphate cement’, Biomed.Mater., 2010, 5, (3).
98.
HuanZG, ChangJ and HuangXH: ‘Self-setting properties and in vitro bioactivity of Ca2SiO4/CaSO4 center dot 1/2H(2)O composite bone cement’, J. Biomed. Mater. Res. Part B–Appl. Biomater., 2008, 87B, 387–394.
99.
ZhaoWY, ChangJ and ZhaiWY: ‘Self-setting properties and in vitro bioactivity of Ca3SiO5/CaSO4 center dot 1/2H2O composite cement’, J. Biomed. Mater. Res. Part A, 2008, 85A, 336–344.
100.
HuanZ and ChangJ: ‘Self-setting properties and in vitro bioactivity of calcium sulfate hemihydrate-tricalcium silicate composite bone cements’, Acta Biomater., 2007, 3, 952–960.
101.
YangCS, HoCC and DingSJ: ‘Hollow calcium carbonate/calcium silicate microspheres for drug delivery’, J. Tissue Eng. Regen Med., 2012, 6, 328.
102.
SuJ, WangZ, YanY, WuY, CaoL, MaY, YuB and LiM: ‘Nanoporous calcium silicate and PLGA biocomposite for bone repair’, J. Nanomater., 2010, (2010), 181429.
103.
DouYD, WuCT and ChangJ: ‘Preparation, mechanical property and cytocompatibility of poly(L-lactic acid)/calcium silicate nanocomposites with controllable distribution of calcium silicate nanowires’, Acta Biomater., 2012, 8, 4139–4150.
104.
WeiJ, HeoSJ, LiC, KimDH, KimSE, HyunYT, ShinJW and ShinJW: ‘Preparation and characterization of bioactive calcium silicate and poly(epsilon-caprolactone) nanocomposite for bone tissue regeneration’, J. Biomed. Mater. Res. Part A, 2009, 90A, 702–712.
105.
ZhuHL, WuBW, FengXX and ChenJY: ‘Preparation and characterization of bioactive mesoporous calcium silicate-silk fibroin composite films’, J. Biomed. Mater. Res. Part B–Appl. Biomater., 2011, 98B, 330–341.
106.
DingSJ, WeiCK and LaiMH: ‘Bio-inspired calcium silicate-gelatin bone grafts for load-bearing applications’, J. Mater. Chem., 2011, 21, (12) 793–802.
107.
DingSJ, ShieMY and WeiCK: ‘In vitro physicochemical properties, osteogenic activity, and immunocompatibility of calcium silicate-gelatin bone grafts for load-bearing applications’, ACS Appl. Mater. Interfaces, 2011, 3, 4142–4153.
108.
ChenCC, WangWC and DingSJ: ‘In vitro physiochemical properties of a biomimetic gelatin/chitosan oligosaccharide/calcium silicate cement’, J. Biomed. Mater. Res. Part B–Appl. Biomater., 2010, 95B, 456–465.
